WHWK

Whitehawk Therapeutics Inc

Insider Trades

NameValueActionPriceCurrent Price
Ball BryanSee Remarks
$6.1k1.8k shares
SellMar 2, 2026
$3.31
--
Giacobello Scott M.CHIEF FINANCIAL OFFICER
$8.6k2.6k shares
SellMar 2, 2026
$3.31
--
Lennon David JamesDirector, Officer: CHIEF EXECUTIVE OFFICER
$17k5.1k shares
SellMar 2, 2026
$3.31
--
Lennon David JamesDirector, Officer: CHIEF EXECUTIVE OFFICER
$93k26.9k shares
SellApr 2, 2026
$3.48
--
Lennon David JamesDirector, Officer: CHIEF EXECUTIVE OFFICER
$217k63.9k shares
SellApr 8, 2026
$3.40
--
Lennon David JamesDirector, Officer: CHIEF EXECUTIVE OFFICER
$323k94.1k shares
SellApr 7, 2026
$3.43
--

News

gurufocus.comWhitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026gurufocus.comMay 30prnewswire.comWhitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026prnewswire.comMay 30prnewswire.comWhitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conferenceprnewswire.comMay 28prnewswire.comWhitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payloadprnewswire.comMay 21prnewswire.comWhitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summitprnewswire.comMay 20